打破障碍:通过向NLRP3炎症酶来克服癌症耐药性
Nazanin Pazhouhesh Far1, Mahsa Hajiheidari Varnousafaderani2, Ferdos Faghihkhorasani3
1Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Science, Islamic Azad University, Tehran, Iran.
British journal of pharmacology
|October 12, 2024
概括
炎症通过促进转移和入侵驱动癌症. NOD-Like受体蛋白3 (NLRP3) 炎症酶在这些过程中发挥着关键作用,并为癌症治疗提供了潜在的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 炎症是癌症开始和进展的组成部分,影响转移,血管新生,扩散和入侵.
- 瘤微环境 (TME) 和炎症性细胞因子协调这些与癌症相关的事件.
- 通过模式识别受体激活炎症性卡斯帕斯,特别是卡斯帕斯-1,会导致促炎性细胞因子的释放 (IL-1β,IL-18).
研究的目的:
- 审查NOD-Like受体蛋白3 (NLRP3) 炎症体的结构,生物特征和机制.
- 阐明NLRP3炎症酶激活和TME内的与瘤相关的免疫反应之间的关系.
- 通过NLRP3炎症酶调制探索针对癌症的治疗策略.
主要方法:
- 文献综述侧重于癌症中的NLRP3炎症酶功能的研究.
- 对NLRP3在不同癌症类型的瘤发生中的双重作用的分析.
- 探索新的治疗方法,包括纳米粒子,基因疗法和免疫检查点抑制剂.
主要成果:
- NLRP3炎症酶激活与炎症性疾病和癌症有关.
- NLRP3在瘤发生过程中表现出上下文依赖的作用,抑制结肠直肠癌,但促进胃癌和皮肤癌.
- NLRP3炎症酶对瘤免疫反应和TME产生影响.
结论:
- NLRP3炎症酶是炎症的关键调节者,在癌症中具有重大影响.
- 调节NLRP3炎症组为各种癌症提供了有前途的治疗途径.
- 向NLRP3为癌症治疗提供了创新的策略,包括基于纳米粒子和基因向疗法.
相关概念视频
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Cells of the Innate Immune Response
1.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


